124 related articles for article (PubMed ID: 16603650)
21. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
Med Oncol; 2010 Sep; 27(3):867-75. PubMed ID: 19763915
[TBL] [Abstract][Full Text] [Related]
23. Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.
Lou X; Sun B; Song J; Wang Y; Jiang J; Xu Y; Ren Z; Su C
Oncotarget; 2016 Dec; 7(51):84486-84495. PubMed ID: 27806323
[TBL] [Abstract][Full Text] [Related]
24. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
25. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
28. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells.
Haage A; Schneider IC
FASEB J; 2014 Aug; 28(8):3589-99. PubMed ID: 24784579
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer.
Chen Z; Fan JQ; Li J; Li QS; Yan Z; Jia XK; Liu WD; Wei LJ; Zhang FZ; Gao H; Xu JP; Dong XM; Dai J; Zhou HM
Int J Cancer; 2009 Feb; 124(3):739-44. PubMed ID: 19006069
[TBL] [Abstract][Full Text] [Related]
30. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
31. p8 expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis.
Sandi MJ; Hamidi T; Malicet C; Cano C; Loncle C; Pierres A; Dagorn JC; Iovanna JL
J Cell Physiol; 2011 Dec; 226(12):3442-51. PubMed ID: 21344397
[TBL] [Abstract][Full Text] [Related]
32. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
[TBL] [Abstract][Full Text] [Related]
33. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.
Kataoka H; Uchino H; Iwamura T; Seiki M; Nabeshima K; Koono M
Am J Pathol; 1999 Feb; 154(2):457-68. PubMed ID: 10027404
[TBL] [Abstract][Full Text] [Related]
34. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
[TBL] [Abstract][Full Text] [Related]
35. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.
Roy D; Mondal S; Khurana A; Jung DB; Hoffmann R; He X; Kalogera E; Dierks T; Hammond E; Dredge K; Shridhar V
Sci Rep; 2017 Feb; 7():41977. PubMed ID: 28169314
[TBL] [Abstract][Full Text] [Related]
36. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
37. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
[TBL] [Abstract][Full Text] [Related]
38. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
[TBL] [Abstract][Full Text] [Related]
39. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
Fujioka S; Sclabas GM; Schmidt C; Niu J; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
Oncogene; 2003 Mar; 22(9):1365-70. PubMed ID: 12618762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
